Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients.

Fayette, Jérôme; Fontaine-Delaruelle, Clara; Ambrun, Alexis; Daveau, Clémentine; Poupart, Marc; Ramade, Antoine; Zrounba, Philippe; Neidhardt, Eve-Marie; Péron, Julien; Diallo, Alpha; Céruse, Philippe

Fayette, Jérôme; Fontaine-Delaruelle, Clara; Ambrun, Alexis; Daveau, Clémentine; Poupart, Marc; Ramade, Antoine; Zrounba, Philippe; Neidhardt, Eve-Marie; Péron, Julien; Diallo, Alpha; Céruse, Philippe.

Afiliación

Fayette J; Department of Medicine, Léon Bérard Center, University of Lyon, Lyon, France.
Fontaine-Delaruelle C; Department of Medicine, Léon Bérard Center, University of Lyon, Lyon, France.
Ambrun A; Department of Surgery, Croix-Rousse Hospital, University of Lyon, Lyon, France.
Daveau C; Department of Surgery, Edouard Herriot Hospital, University of Lyon, Lyon, France.
Poupart M; Department of Surgery, Croix-Rousse Hospital, University of Lyon, Lyon, France.
Ramade A; Department of Surgery, Edouard Herriot Hospital, University of Lyon, Lyon, France.
Zrounba P; Department of Surgery, Léon Bérard Center, University of Lyon, Lyon, France.
Neidhardt EM; Department of Medicine, Léon Bérard Center, University of Lyon, Lyon, France.
Péron J; Department of Medical Oncology, Institut du Cancer des Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, University of Lyon, Pierre-Bénite, France.
Diallo A; CNRS-UMR 5558, Biometry and Evolutive Biology Laboratory, Health and Biostatistics Team, Villeurbanne, France.
Céruse P; Department of Surgery, Lyon Sud Hospital Center, University of Lyon, Pierre-Bénite, France.

Oncotarget ; 7(24): 37297-37304, 2016 Jun 14.

Article en En | MEDLINE | ID: mdl-27119503

Asunto(s)

Antineoplásicos/uso terapéutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Carcinoma de Células Escamosas/tratamiento farmacológico; Neoplasias de Cabeza y Cuello/tratamiento farmacológico; Terapia Neoadyuvante/métodos; Factores de Edad; Anciano; Anciano de 80 o más Años; Antineoplásicos/efectos adversos; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Carcinoma de Células Escamosas/mortalidad; Carcinoma de Células Escamosas/patología; Carcinoma de Células Escamosas/radioterapia; Cisplatino/efectos adversos; Cisplatino/uso terapéutico; Supervivencia sin Enfermedad; Docetaxel; Femenino; Fluorouracilo/efectos adversos; Fluorouracilo/uso terapéutico; Estudios de Seguimiento; Anciano Frágil; Neoplasias de Cabeza y Cuello/mortalidad; Neoplasias de Cabeza y Cuello/radioterapia; Humanos; Masculino; Persona de Mediana Edad; Terapia Neoadyuvante/efectos adversos; Estadificación de Neoplasias; Estudios Retrospectivos; Taxoides/efectos adversos; Taxoides/uso terapéutico

Palabras clave

TPF; cisplatin; frail patients; head and neck cancer; induction

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Neoplasias de Cabeza y Cuello / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google